Sponsor: Grayken Center for Addiction TTA; a program of Boston Medical Center
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
Description
This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.
Intended audience
Providers and nurses working in OTP, OBAT, primary care, inpatient, ED, etc.
For more information and to register click here
Event Details
- Date:
- December 11, 2024
- Time:
- 9:00 am - 10:00 am
- Location:
- virtual
- Cost:
- free